Simons M - Search Results

1

The impact of clinical data on interpretation of thallium scintigrams.

Simons M, Parker JA, Donohoe KJ, Udelson JE, Gervino EV. Simons M, et al. J Nucl Cardiol. 1994 Jul-Aug;1(4):365-71. doi: 10.1007/BF02939957. J Nucl Cardiol. 1994. PMID: 9420719

2

Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.

Simons M, Isner JM. Simons M, et al. Am J Cardiol. 1992 Feb 1;69(4):425-7. doi: 10.1016/0002-9149(92)90250-3. Am J Cardiol. 1992. PMID: 1734663 No abstract available.

3

Aortic root dimension measurement by first-pass radionuclide angiography.

Martins LR, Simons M, Kolodny GM, Parker JA, Warren SE. Martins LR, et al. Among authors: simons m. Am J Physiol Imaging. 1991 Jul-Sep;6(3):116-20. Am J Physiol Imaging. 1991. PMID: 1772692

4

Fuzzy logic, sharp results.

Simons M, Parker JA. Simons M, et al. J Nucl Med. 1995 Aug;36(8):1415-6. J Nucl Med. 1995. PMID: 7629587 Free article. No abstract available.

5

The role of clinical data in interpretation of perfusion images.

Simons M, Parker JA, Udelson JE, Gervino EV. Simons M, et al. J Nucl Med. 1994 Apr;35(4):740-1. J Nucl Med. 1994. PMID: 8151406 Free article. No abstract available.

6

Myocardial perfusion scintigraphy: effect on diagnostic and clinical management algorithms.

Better N, Parker JA, Rocco TP, Simons M, Gervino EV. Better N, et al. Among authors: simons m. J Nucl Med. 1996 Oct;37(10):1618-21. J Nucl Med. 1996. PMID: 8862294 Free article.

7

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK. Simons M, et al. Circulation. 2000 Sep 12;102(11):E73-86. doi: 10.1161/01.cir.102.11.e73. Circulation. 2000. PMID: 10982554 Review.

8

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease.

Udelson JE, Dilsizian V, Laham RJ, Chronos N, Vansant J, Blais M, Galt JR, Pike M, Yoshizawa C, Simons M. Udelson JE, et al. Among authors: simons m. Circulation. 2000 Oct 3;102(14):1605-10. doi: 10.1161/01.cir.102.14.1605. Circulation. 2000. PMID: 11015335 Clinical Trial.

9

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

Laham RJ, Chronos NA, Pike M, Leimbach ME, Udelson JE, Pearlman JD, Pettigrew RI, Whitehouse MJ, Yoshizawa C, Simons M. Laham RJ, et al. Among authors: simons m. J Am Coll Cardiol. 2000 Dec;36(7):2132-9. doi: 10.1016/s0735-1097(00)00988-8. J Am Coll Cardiol. 2000. PMID: 11127452 Free article. Clinical Trial.

10

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.

Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA. Simons M, et al. Circulation. 2002 Feb 19;105(7):788-93. doi: 10.1161/hc0802.104407. Circulation. 2002. PMID: 11854116 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,530 results

Search Page

Filters